Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06626685 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clonal Hematopoiesis of Indeterminate Potential in Heart Failure.

Study acronym: RICO-HF
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv8
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2025 to Mar 10, 2025
    • Site details revised at 2 of 2 sites
    v7
  3. Start date: Feb 1, 2025 to Apr 1, 2025v6
  4. Start date: Jan 1, 2025 to Feb 1, 2025v5
  5. Start date: Nov 1, 2024 to Jan 1, 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Oct 1, 2024 to Nov 1, 2024v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is part of the Rico Macro-Project, a multidisciplinary research program promoted by FROM in collaboration with the ASST-PG23 and ATS Bergamo, aiming to investigate the role of clonal hematopoiesis on inflammation, studying in depth the mechanisms underlying the inflammatory process to determine their correlation with some important pathologies in different clinical fields (Hematology, Cardiology, Neurology, Pneumology, Gastroenterology, and Diabetology, etc.). In this context, the prospective observational study RICO-HF is developed. The RICO HF is the first project focused on CHIP and inflammation in the area of Cardiology, specifically in HF.
Trial Details
NCT Number NCT06626685
Lead Sponsor FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov